Big Stakes at the 15th Annual 168 Film Festival

Tea McKay Hugs Dreamer on UNBRIDLED

T.C. Stallings as Detective Sangrin in UNBRIDLED

Nathan Kress (iCarly) on Kids Red Carpet 2014

Sponsors and Stars Salute Faith-Based Filmmaking

BURBANK, CA, USA, August 3, 2017 / — On August 26th-27th the fifteenth annual 168 Film Festival unspools at Regal Cinemas Premiere House at LA Live, 1000 W Olympic Blvd, LA, CA 90015. Tickets are available now and more info at

The grand prize pits nine finalist producers of short films against each other. Ultimately, only one will be selected to make a feature film with Studio 8168 in 2018. The film will benefit 168 Film, the non-profit corporation behind the 168 Film Festival.

The event is sponsored by industry pros as well as household names, including, Panasonic Cinema, Panavision, Sony, Tiffen/Steadicam, Arri, Roush Media, Advent Media, Inc., Location Sound and Marshall Electronics.

The 2017 prize package also includes $10,000 in rentals provided by Panavision and Post Production Services provided by Roush Media, which also provided DCP files for all screenings. Production gear is provided by Tiffen/Steadicam and Marshall Electronics.

Saturday from 4:30-5:30 Michael Cioni, Product Director of the new 8K Panavision Millennium DXL Camera will discuss "10 Golden Nuggets of Independent Filmmaking: Making the Most of Limited Resources.” A hands-on DXL demo will follow.

Saturday screenings are from 9:00 am-4:00 pm. The kids screening and kids red carpet is 9:00 am to 11:00 am. At 7:00 pm, the feature film UNBRIDLED screens starring T.C. Stallings (War Room), Eric Roberts (The Dark Knight) and introducing Tea McKay. UNBRIDLED is directed by 168 Founder and President, John David Ware.

On Sunday, Aug. 27, 12:30 pm to 1:50 pm, Panasonic Cinema will give a presentation and panel discussion, as industry experts review the full line of Panasonic Cine-style cameras and share tips to minimize production costs while maximizing quality.

Sunday screenings are 9:00 am to 7:30 pm with a worship service from 9:00 am to 9:45 am.

Stars including T.C. Stallings arrive on the Red Carpet from 3:45 pm to 5:45 pm and the 168 Film Festival Awards Show is 8:00 pm-9:30 pm. The festival event schedule is available at

According to Ware, “Our prize package reflects the mountain our filmmakers have climbed. Our sponsors encourage and empower them to continue producing excellence.”
For interviews or to obtain press kits, B-roll, stills or film clips, contact 168 Film at 818-557-8507. For more info, visit

Mark Baird
168 Film
email us here

Unbridled Teaser

Source: EIN Presswire

Intiva BioPharma Submits a Request to the FDA for a Pre-Investigational New Drug Meeting

Cannabinoid and/or Terpene Drug Candidate is for Use in the Acute Treatment During and Immediately Following Exposure to Nerve Agents

Cannabinoids including THC and CBD, and various terpenes may offer significant clinical and military benefit as compared to currently available drugs used as centrally-acting nerve antidotes.”

— Jeffrey Friedland

DENVER, COLORADO, UNITED STATES, August 2, 2017 / — Intiva BioPharma Inc. submitted a Request and an amendment to the Request for a Pre-Investigational New Drug (IND) Meeting with the Food and Drug Administration (“FDA”) to discuss the development of an injectable product for use in the acute treatment during and immediately following exposure to organophosphorous nerve agents.

After discussions with representatives of the FDA, the Company subsequently submitted a revised Request incorporating the changes to the Request reflected in the amendment for administrative purposes. The proposed product consists of one or more cannabinoids and one or more terpenes and is to be used in conjunction with Atropine Sulfate and Pralidoxime Chloride.

Organophosphorous nerve agents have been developed for use as chemical warfare nerve agents by conventional armies, military special forces, desperate regimes and/or terrorists.

Sarin, a highly potent organophosphorous nerve agent, was used by Saddam Hussein’s Republic of Iraq against Kurdish civilians in March 1998 killing at least 3,200 people and injuring many more people.

The 1995 Tokyo subway attack by a “religious cult” used Sarin to injure many citizens.

The use of Sarin in multiple occasions in the Syrian conflict resulted in many casualties and alarmed the international community about the continued risks associated with nerve agents such as Sarin.

Additionally, a “VX” class of nerve agents which is even more lethal than Sarin was allegedly used most recently in the murder of Kim Jong-nam in Malaysia.

The drug candidate will be investigated for use in the acute treatment as a neuroprotectant and the prevention and/or reducing the frequency and severity of seizures during or immediately following exposure to organophosphorous nerve agents.

Jeffrey Friedland, CEO of Intiva BioPharma stated that, “the cannabinoids including tetrahydrocannabinol (THC) and cannabidiol (CBD) and various terpenes may offer significant clinical and military benefit as compared to the currently available product used as centrally-acting nerve antidotes.” He went on to say, “the use of combinations of cannabidiol and other phytocannabinoids with terpenes may provide synergistic effects in the areas of nerve protection and seizures.”

INTIVA BioPharma has assembled a team of experienced professionals in pharmaceutical development and regulatory compliance for its drug development activities.

About INTIVA BioPharma Inc.

INTIVA BioPharma is proceeding with pre-clinical and clinical drug development activities, in accordance with U.S. Food and Drug Administration ("FDA") protocols, for a number of pharmaceutical formulations that include cannabinoids.

BioPharma’s drug development strategy consists of:

The determination of medical conditions and disorders that could potentially benefit from cannabinoid-based formulations;

Conducting “freedom to operate” investigations on these conditions;

The preparation of patent applications and the prosecution of such application and/or the licensing of existing patents;

Identifying the regulatory pathway with the U.S. Food and Drug Administration (FDA); and

Proceeding with pre-clinical and clinical development activities in accordance with FDA protocols for submission to investigate and ultimately obtain approval for the particular product(s).

INTIVA BioPharma is currently researching and developing proprietary pharmaceutical formulations consisting of different cannabinoids and terpenes.

Due to the legal and regulatory challenges in researching cannabinoids derived from the cannabis plant in the United States, INTIVA BioPharma is initially focused on developing drugs utilizing synthetic cannabinoids. If the Company intends to proceed in researching pharmaceuticals derived from the cannabis plant, it will proceed with the research and trials in a country where the research is legal, such as Israel, and not in the U.S.

INTIVA Disclosure Notice: This press release contains “forward-looking statements” as that term is defined in the Private Securities Litigation Reform Act of 1995. For this purpose, any statements contained herein or which are otherwise made by or on behalf of the Company that are not statements of historical facts may be deemed forward-looking statements. Without limiting the generality of the foregoing, words such as “may,” “will,” “to,” “plan,” “expect,” “believe,” “anticipate,” “intend,” “could,” “should,” “would,” “estimate,” or “continue,” or the negative or other variations thereof or comparable terminology are intended to identify forward-looking statements. Readers are cautioned that all forward-looking statements involve risk and uncertainties which may cause results to differ materially from those set forth in the statements. Such risks and uncertainties include, but are not limited to the following: the success of research and development activities and the speed with which regulatory authorizations and product launches may be achieved; government regulation generally; competitive developments; the ability to successfully market products domestically and internationally; difficulties or delays in manufacturing or issues relating to manufacturing capacity; commercial obstacles to the successful introduction of brand products generally; legal defense costs, insurance expenses, settlement costs, and the risk of an adverse decision or settlement relating to product liability, patent protection, governmental investigations, and other legal proceedings; the Company’s ability to acquire and protect patents and other intellectual property both domestically and internationally; the absence of certainty regarding the receipt of required regulatory approval or the timing or terms of such approvals; any changes in business, political and economic conditions; business interruption due to hurricanes or other events outside of the Company’s control.

Readers are cautioned not to place reliance on these forward-looking statements, which are valid only as of the date they were made. The Company undertakes no obligation to update or revise any forward-looking statements to reflect new information or the occurrence of unanticipated events or otherwise, except as expressly required by law.

Jeffrey Friedland
Chief Executive Officer
INTIVA BioPharma Inc.
Tel. 1-800-497-2915

Jeffrey Friedland
Friedland Global Capital
email us here

Source: EIN Presswire

Myositis Support and Understanding Association Turns Two and wishes for Myositis patients to Celebrate their Caregivers

Myositis Support and Understanding Association logo

Myositis Support and Understanding Association, Inc.

"Celebrate your Myositis Caregiver" in recognition of MSU's second year

“Celebrate your Myositis Caregiver” in recognition of MSU’s second year

You are more than a caregiver

Some people experience a loss of the roles and relationships they had with their loved one before chronic illness. Make an effort to retain the relationship you have had with your loved one

MSU asks myositis patients to “Celebrate your Caregiver” in recognition of its two-year anniversary as a non-profit.

Myositis is an opportunity for us to be aware and intentional every day with our loved ones, a constant reminder to reflect and be grateful for the abilities we have and the people we love.”

— Rick Boling, a family member of a myositis patient

LINCOLN, DE, UNITED STATES, August 1, 2017 / — MSU is a 501(c)(3) non-profit organization founded on July 30, 2015, for patients living with, and for loved ones caring for someone with, Myositis, a rare and debilitating autoimmune disease. Myositis is a rare disease estimated to affect between only 50,000-75,000 people in the United States.

In recognition of everything Myositis Caregivers provide, MSU is asking patients to “Celebrate their Caregivers” and share the experience through videos, photographs, and articles to be distributed on the Myositis Support and Understanding website and social networking sites.

"Myositis is an opportunity for us to be aware and intentional every day with our loved ones, a constant reminder to reflect and be grateful for the abilities we have and the people we love." Rick Boling, a family member of a myositis patient and co-caregiver with the rest of the family.

Due to the nature of the Idiopathic Inflammatory Myopathies, patients often experience debilitating muscle weakness, fatigue, chronic pain, uncomfortable to painful skin rashes, trouble swallowing, lung disease, as well as other organ involvement. In some cases, especially with Inclusion Body Myositis (IBM) and refractory cases or advanced forms of polymyositis, dermatomyositis, or necrotizing autoimmune myopathy, full disability can occur in which patients require full assistance with activities of daily living, known as ADL’s. When patients progress to this level of disability caregivers become a necessity for patients to function.

Myositis caregivers dedicate themselves to ensuring that their loved ones maintain a level of human dignity and independence, often allowing them to stay in their homes longer than they could without assistance. Family members expand their roles in the lives of the patient far past the role of typical spouse, child, sibling, parent, friend, cousin, to that of nurse, bather, cook, housekeeper, dressing assistant, medication giver, lifter, chauffeur, massage therapist, hugger, cheerleader, doctor appointment companion, patient advocate, medical bill juggler, grocery shopper, and so much more. Myositis Caregivers give help that is immeasurable. It is always appreciated, if not always acknowledged as it is sometimes embarrassing for the patient. Caregiving is a difficult task by itself, let alone for those who also hold down full-time employment. Sometimes the dual role as spouse and caregiver can bring couples closer together or, as we have seen in some cases, tear their marriage apart; this is yet another unfortunate side effect of myositis.

Penny Bundy, Treasurer of MSU says, "My caregiver is my husband of 27 years, who has more than willingly stepped forward to take over household chores, cooking and whatever I find myself unable to do. But even more than that, while I am quite happy to putter around the house doing what chores I can, or work on my computer, or just sit and read, he reminds me that I need to get out doors to enjoy the fresh air and the sunshine. If not for him, I would sit indoors all day just watching the world go by. Going out is such a chore for me that I repeatedly turn down his offers for a ride or a short shopping trip. But he continues to ask until I finally give in, and discover the rewards of the outing far outweigh the trials of getting out and into the car to go. I appreciate so much that he looks out for my well-being in areas that I forget to watch".

Each patient with myositis is different in what they require as far as physical assistance. Some may only need help with outside of the house things like transportation while others may require around the clock assistance that includes bathing, feeding, toileting, and other activities of daily living (ADL’s).

Caregivers are a diverse group and the definition, as we have seen in our support groups, can be applied to many people in the patient’s life. For some, it is a special friend that lends a hand when needed. For others, it’s their spouse. And yet for some, it may be a professional that visits the home or the patient relocates to an assisted living facility. MSU is focused on ensuring that caregivers get the support they need and deserve.

“We want to ensure that our Myositis caregivers have a safe place to ask questions that are specific to myositis, a place to vent, and the ability to share difficult emotions that often arise. This is why we have an online support group that is specific for caregiver needs and that provides that safe place just for them,” says Jerry Williams, Founder and President of MSU.

What has MSU accomplished over the past two years?

– Through its financial assistance program, MSU has provided thousands of dollars in medical and home expense assistance helping myositis patients keep their homes, pay their medical bills, and ensure they have the necessities to be able to reach out for the support that is so needed when living with a rare disease.
– Hundreds of educational, informative, and supportive articles written specifically for those living with myositis.
– Dozens of interactive, face-to-face video chat sessions hosted for myositis patients and caregivers to get information, education, and support.
– Thousands of member posts hosted in the support groups, answered, and conversed by other patients who understand each other.
– Information disseminated about clinical trials, pertinent products, and the latest myositis research.
– Information pamphlets and literature provided to patients and doctors about myositis and about MSU.
– A constantly growing, interactive, and easy to understand website providing education, support, myositis patient programs, patient-submitted content, and hundreds of resources for myositis patients and caregivers.

Myositis Support and Understanding (MSU) is dedicated to improving the lives of Myositis patients through public policy, self-advocacy programs, need-based financial assistance for medical-related and personal expenses, and to provide support and education to patients, caregivers, healthcare providers, the general public, and legislators about Myositis. MSU was founded by Myositis patients, for Myositis patients.

Jerry Williams
Myositis Support and Understanding Association, Inc.
email us here

Source: EIN Presswire

Statement on the death Dr. Bent Sørensen, Copenhagen, pioneer of torture rehabilitation

Logo of the International Rehabilitation Council for Torture Victims, Copenhagen

Pioneer and elder of the torture rehabilitation movement, Professor Bent Sørensen, MD, DMSc, passed away 30 July 2017

One of the pioneers and elders of the torture rehabilitation movement, Professor Bent Sørensen MD, DMSc, passed away 30 July 2017 in Copenhagen, Denmark, age 93

With his loss, the torture rehabilitation movement has lost one of its giants. In these turbulent times, we will honour his memory by redoubling our efforts to Support Life After Torture.”

— International Rehabilitation Council for Torture Victims

COPENHAGEN, CAPITAL, DENMARK, August 1, 2017 / — The International Rehabilitation Council for Torture Victims, Copenhagen, Denmark, today issued the following statement:

One of the pioneers and elders of the torture rehabilitation movement, Professor Bent Sørensen MD, DMSc, passed away 30 July 2017 in Copenhagen, age 93.

Professor Sørensen, a world renowned expert in burns and plastic surgery, dedicated the last four decades of his life to furthering the rights of torture victims around the world and in Denmark. He will be remembered for his ability to put medical expertise to use in principled and unwavering support of those who suffered the most horrific attacks on human dignity, and for his kind and constructive approach to everyone he met.

Following his appointment as professor of surgery at the University of Copenhagen in 1976, he became increasingly engaged in the work at the Rehabilitation and Research Center for Torture Victims (RCT, which later became the Danish Institute Against Torture, Dignity). There, support was provided to victims -primarily from Latin American dictatorships- to rebuild their lives after severe physical and psychological torture. In 1984, he was elected President of RCT and, along with his wife Dr Inge Genefke, became a leading figure in the global community that today forms the International Rehabilitation Council for Torture Victims (IRCT), a network of over 150 centres that every year provide rehabilitation to more than 100.000 torture victims in 75 countries.

In addition to his activism, Professor Sørensen actively contributed to the building of regional and global structures to eradicate torture and ensure rehabilitation for its victims. In 1987, he was elected Member of the United Nations Committee against Torture and in 1989 of the European Committee for the Prevention of Torture. In both bodies, he formed part of the initial membership and through more than a decade of tireless work helped shape them into strong global champions for torture victims. In the UN Committee against Torture, Professor Sørensen is recognized for always focusing on the needs of victims, and he would consistently question States on what they were doing to ensure rehabilitation support for them.

He was known for his firm and disarming approach to any challenge. About his role in the UN Committee dominated by lawyers, he once observed: “Our first meeting took place in April 1988. The CAT members mostly consisted of lawyers, but also of one minister, one journalist, and of me, the only medical doctor. I remember the dinner offered by the UN on the eve of the meeting. The other nine members looked at me and said: ”What are you doing here? We are dealing with torture”. I answered briefly in the same way: ”What are you doing here? We are dealing with torture”. In this manner, Professor Sørensen always underlined the indispensable contribution that the medical discipline makes to the global struggle against torture due to its deep understanding of the devastating effects of torture on the body and the mind of the victim, and their families and communities. In this way he helped keep alive the spirit of the Amnesty International medical groups that first started supporting torture victims in the early 1970s.

Drs Sørensen and Genefke continued to implement this approach in their work of the Anti-Torture Support Foundation, which they founded after retiring from the IRCT and from where they continued to support the fight against torture and around the world.

As much as he was a globalist, his attention never left his native country, Denmark. Until his death, he continued to insist that global principles must be upheld anywhere in any circumstance. He continuously criticized the Danish Government for its engagement in the war in Iraq, he filed complaints to the UN Committee against Torture against the treatment of Iraqi torture victims seeking asylum in Denmark and supported victims of torture by Danish soldiers in Iraq to seek reparations in the Danish courts. Less than one month before his death, Professor Sørensen co-wrote an op-ed accusing the Danish Government of inaction on recent discoveries of torture against Iraqi detainees.

Professor Sørensen is survived by his wife, Dr Inge Genefke.

With his loss, the torture rehabilitation movement has lost one of its giants. In these turbulent times, we will honour his memory by redoubling our efforts to Support Life After Torture.

Terry Collins
International Rehabilitation Council for Torture Victims
email us here

Source: EIN Presswire

A Guidebook to Going to Federal Prison in the U.S.

Cover of Federal Prison Handbook

The Federal Prison Handbook provides a wealth of information for prisoners, those going to prison, loved ones of prisoners and more.

Christopher Zoukis author

Christopher Zoukis is a prisoner rights and correctional education advocate, author and award-winning writer.

What to expect on your first day, dealing with gangs, making phone calls and more – this new book is the definitive guide to going to a U.S. prison.

A true resource for anyone involved with the prison system.”

— Alan Ellis, America's leading federal criminal defense attorney

PETERSBURG, VA, U.S., August 1, 2017 / — What happens on the first day of prison? Are showers really that scary?

Thousands of people are sent to federal prison each year in the United States. Add to that the many family and loved ones effected when someone they know is going to prison, and you have a larger percentage of the population who have burning questions about life in prison.

Finally, there is a comprehensive, realistic guide to surviving in a federal prison – the Federal Prison Handbook.

“I wanted to provide a definitive guide for individuals facing incarceration, prisoners who are already inside and their friends and family,” says author Christopher Zoukis, a college-educated inmate and prison advocate.

The newly-released Federal Prison Handbook compiles information to not only help prisoners and their loved ones protect themselves and their rights, but to help keep prisoners safe by explaining how to avoid the near-constant conflicts found inside prisons.

Some of the topics inside include:
• What to expect on the day you’re admitted to prison, and how to greet cellmates for the first time
• What to do about sexual harassment or assault
• The best ways to avoid fights, and the options that provide the greatest protection if a fight cannot be avoided
• Medical, psychological and religious services
• How to communicate with the outside world through telephones, computers and mail.
• What you can buy in the official commissary and the underground economy
• How to avoid scams, schemes, theft and other problems
• Comprehensive analysis of Federal Bureau of Prisons policy and regulatory guidelines

About Christopher Zoukis
Christopher Zoukis is an outspoken prisoners rights and correctional education advocate who is incarcerated at FCI Petersburg Medium in Virginia. He is an award-winning writer whose work has been published widely in major publications such as The Huffington Post, Prison Legal News, New York Daily News and various other print and online publications. Learn more about Christopher Zoukis and the Federal Bureau of Prisons at

Media Inquiries
Christopher Zoukis is pleased to speak with media by telephone about topics related to prison education and justice reform. For more information or to book an interview, email or send a request in writing to:
Christopher Zoukis
Federal Correctional Institution Petersburg
P.O. Box 1000, #22132-058
Petersburg, VA 23804

What Others Say About the Federal Prison Handbook:

"A true resource for anyone involved with the prison system." — Alan Ellis, America's leading federal criminal defense attorney

"Provides a wealth of useful information and solid advice. . . [A] treasure trove of penal acumen and knowledge." — Alex Friedmann, Managing Editor, Prison Legal News

"The Federal Prison Handbook is one of my go-to guides for matters related to the federal prison system. An invaluable resource for attorneys . . . , prisoners, and their families." — Jeremy Gordon, federal criminal defense and appellate attorney, General Counsel of Prisology

"This is the most informative . . . prison handbook that we've ever seen; and we've seen them all." — Mark Varca, expert attorney and Chairman of FedCURE

Kamea Zelisko
MKT Communications
email us here

What Happens in Prison? New Federal Prison Handbook Answers all Questions

Source: EIN Presswire

IT Governance releases new version of its EU GDPR Documentation Toolkit to help organisations initiate compliance

IT Governance, the global cybersecurity experts.

ELY, CAMBRIDGESHIRE, UNITED KINGDOM, August 1, 2017 / — IT Governance, the leading provider of data protection compliance services and expertise, is pleased to release a new and updated version of its successful EU General Data Protection Regulation (GDPR) Documentation Toolkit.

The EU GDPR Documentation Toolkit is designed to help organisations prepare all the critical documents needed in order to meet and comply with the GDPR requirements. It provides a comprehensive set of customisable document templates developed by legal and GDPR experts, and is designed to save data protection professionals involved in a GDPR compliance project weeks of work.

The new version of the toolkit brings significant changes, encompassing new tools, features and content that has been developed and improved to address feedback from IT Governance’s privacy team and clients.

IT Governance clients that have already purchased the EU GDPR toolkit will automatically receive the new and updated version upon release. v2.0 of the GDPR Documentation Toolkit will contain tracked changes and will be supplied to all existing v1.0 customers.

Alan Calder, the founder and chief executive officer of IT Governance, says: “Effective data protection is now a core competence that all organisations must develop and sustain internally in line with the GDPR. Professionals involved in GDPR compliance have the option to save time and resources by using the GDPR Documentation Toolkit to develop suitable policies, and to manage and implement processes, in order to build a strong data security posture and achieve compliance with the Regulation.

“The new version of the toolkit includes improvements to existing content to address industry feedback and to ensure organisations are equipped with the most effective tool to start a GDPR compliance project.”

The documentation toolkit holds all the documentation required for GDPR compliance, including guidelines for mapping the flow of data, a privacy audit procedure, data breach processes and procedures, international transfer procedures, consent templates, information security policies and much more.

To find out more about IT Governance’s GDPR compliance services, or to download the new version of the GDPR Documentation Toolkit, please visit our website, contact our team direct at or call on +44 (0)845 070 1750.

– Ends –


IT Governance Ltd is the single-source provider of books, tools, training and consultancy for IT governance, risk management and compliance. It is a leading authority on data security and IT governance for business and the public sector. IT Governance is ‘non-geek’, approaching IT issues from a non-technology background and talking to management in its own language. Its customer base spans Europe, the Americas, the Middle East and Asia. More information is available at

Mihaela Jucan
IT Governance Ltd
email us here

Source: EIN Presswire

Female Ex-Offender Turns Inmates into Authors

From Inmate, to Author, View Tanner George Cummings The Cell Chef Cookbook

Over 120 recipes, from the dips to pizza to burritos in your cell

Anthony Tinsman's first book: Life With a Record

How To Leave Prison Prepared and Live Successfully

Over 1000 resources in the new Inmate Shopper 2017-18

America’s Largest Book of Resources for Inmate Services

Diane E. Schindelwig of Freebird Publishers has published over 50 titles for inmate authors since 2013.

NORTH DIGHTON, MA, UNITED STATES, July 31, 2017 / — In a recent NBC interview Diane said: “I had no idea inmates were so content deprived until I became one in 2008. By 2012 I knew my new life would include publishing specialty content for inmates and their families. Only one problem, I knew nothing about publishing except how to push “print” on a computer.

“This whole entrepreneurial adventure has been on-the-job training, but we made it. With no knowledge of how to create a book exactly, I used my past business experience and practices to guide my way.

There’s definitely an abundance of talented people in prison, knowledgeable writers creating content from their first-hand experiences. All they needed was a publisher that understood their niche."

Diane E. Schindelwig
Freebird Publishers
email us here

Source: EIN Presswire

Global Biosimilars And Follow-On Biologics Market Worth $21.6bn in 2021



New market study launched by

AMSTERDAM, NETHERLANDS, July 31, 2017 / — This news report, now available on ASDReports, Global Biosimilars and Follow-On Biologics Market 2017-2027: Monoclonal Antibodies (mAbs), Fusion Proteins, Insulin, Erythropoietins, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Growth Hormones, Fertility Hormones indicates that the global biosimilars and follow-on biologics market will see $21.6bninspending in 2021.

The global biosimilars and follow-on biologics market is expected to grow at a CAGR of 38.8% in the first half of the forecast period and CAGR of 11.3% in the second half of the forecast period. The market is estimated at $5.31bn in 2016 and $41.07bn in 2027.

The lead analyst of the report said: “In 2016, three sectors – biosimilar EPO, biosimilar insulin, biosimilar monoclonal antibodies, and biosimilar growth hormones – accounted for more 60.6% of market revenues. The first two of these sectors will record strong growth throughout the next ten years. Growth will be restrained in the biosimilar growth hormones submarket by steady uptake for branded therapies, high brand loyalty, as well as the launch of long-acting growth hormones. Rising diabetes incidence will drive demand for biosimilar human insulin in emerging markets, while the launch of biosimilar insulin glargine in developed markets during the forecast period will drive growth in the biosimilar insulin analogues sector.

Biosimilar mAbs (monoclonal antibodies) will be the fastest growing sector of the biosimilars market between 2016 and 2027, with a high 12-year CAGR of 31.6%, with revenues growing from just $1.056bn in 2016 to $9.8bn in 2027.”

The 318-page report contains 128 tables and 68figures that add visual analysis in order to explain the developing trends within the Global Biosimilars and Follow-on Biologics Market.

More reports on Biosimilars can be found on ASDReports. Find more Life Sciences reports on ASDReports as well.

Stefan Koopman
email us here

Source: EIN Presswire

U.S. Counter-Terrorism Unit Targets Virginia Prisoner for Writing About Prison

Christopher Zoukis author and prisoner attached by U.S. Counter-Terroism Unit

Prisoner, prisoner advocate and author Christopher Zoukis has been targeted by the U.S. Counter-Terrorism Unit for his prison writing.

Three images of Christopher's Zoukis' book covers, Federal Prison Handbook, College for Convicts and Prison Education Guide

Zoukis has been targeted by the Federal Bureau of Prisons before – usually after each of his books are published.

Christopher Zoukis author

Christopher Zoukis is a prisoner rights and correctional education advocate, author and award-winning writer.

An American prisoner, prisoner advocate and author was recently targeted by the U.S. Counter-Terrorism Unit for his prison writing activities.

Instead of investigating terrorists the federal prison’s CTU seems preoccupied with finding creative ways to shut up a single prison writer who has absolutely nothing to do with terrorism.”

— Christopher Zoukis

PETERSBURG, VA, U.S., July 31, 2017 / — An American-born prisoner, prisoner advocate and author was recently targeted by the U.S. Counter-Terrorism Unit for his writing activities in a clear case of attempted censorship by the Federal Bureau of Prisons.

“I’m a U.S.-born citizen with no ties to any terrorist organization, I don’t understand why I’m being targeted like this,” says Christopher Zoukis, a current inmate at FCI Petersburg Medium serving time for sexual offences he was found guilty of in 2004.

Zoukis was just recently released from six weeks of solitary confinement at Petersburg after three incident reports were taken out against him by a member of the Federal Bureau of Prison’s Counter Terrorism Unit (CTU), an intelligence agency tasked with investigating and preventing terrorist acts within U.S. borders.

Specifically, he was charged with conducting a business and unauthorized contact with the public for his involvement. The charges seem to stem from Zoukis’ involvement in a free, electronic news service for prisoners called, publishing three books, running three education-based websites and an interview he did on the phone where he discussed one of his books as well as the underground economies of prisons.

“Instead of investigating terrorists and trying to foil plots, the Federal Bureau of Prison’s CTU seems to be preoccupied with finding creative ways to shut up a single prison writer who has absolutely nothing to do with terrorism,” says Zoukis. “Instead of focusing on ISIS threats or other terrorist plots, they are spending their time and taxpayer money focusing on what I post at and the content of my latest book or interview.”

While this isn’t the first time Zoukis has been targeted for his writing activities (Zoukis has previously had seven incident reports for the same charges in 2012 and 2014 which were expunged), and it’s certainly not the first time a prisoner has undergone attack for writing about federal prisons, it is the first time the CTU has become involved.

So, what led this unit to take notice of Zoukis in the first place? In March of this year, the same official from the CTU instituted a ban on the service, which was overturned in April. Shortly after that, this official contacted the Petersburg Special Investigative Services (SIS) department to get them to write incident reports against Zoukis. The Petersburg officials refused, as they had already laid those same charges previously and Zoukis was found not guilty. Just after that, the CTU official laid the charges himself. As a result, Zoukis was placed in solitary confinement for six weeks before seeing the Discipline Hearing Officer, while other prisoners were kept for one to two weeks maximum. Zoukis was found guilty of the business charges, not guilty of the other charges, and was released from solitary in mid-July. He plans on appealing the guilty charge.

The federal prison’s CTU involvement in a writer’s activities is concerning as it threatens free speech and First Amendments rights, but also that terrorism funds are being used to seemingly censor a prison writer. 

For information on past charges and other details regarding this situation, visit this helpful Q & A article.

For more information, please direct media inquiries to:
Rachel Sentes

About Christopher Zoukis
Christopher Zoukis is an outspoken prisoner rights and correctional education advocate who is incarcerated at FCI Petersburg Medium in Virginia. He is an award-winning writer whose work has been published widely in major publications such as The Huffington Post, Prison Legal News, New York Daily News and various other print and online publications. Learn more about Christopher Zoukis at, and

Rachel Sentes
Gal-Friday Publicity
email us here

American Prisoner Targeted by Counter Terrorism Unit

Source: EIN Presswire

Macedonian Human Rights Organizations Condemn the So-Called Macedonia/Bulgaria "Friendship Agreement"

Macedonian Human Rights Movement International

The Agreement between Macedonia and Bulgaria is inequitable, satisfies Bulgarian nationalistic aspirations and calls into question the sovereignty of Macedonia.

We therefore consider the Agreement unacceptable, insulting to Macedonia and the Macedonian people, unprincipled and shameful for both signatory countries.”

— Stojko Stojkov, OMO Ilinden PIRIN

TORONTO, CANADA, July 31, 2017 / — Macedonian Human Rights Organizations Condemn the So-Called Macedonia/Bulgaria “Good Neighbourliness” Agreement

(July 31, 2017) – While we express our in-principle support for good neighbourly relations, advancement of relations and the integration of Macedonia into European and Atlantic structures, we cannot at the same time not condemn the contents of this agreement which, despite all the fine phrases, is in fact contrary to the abovementioned values.

The Agreement on Good Neighbourliness between Macedonia and Bulgaria is inequitable and satisfies Bulgarian nationalist aspirations more than it does Macedonian national interests. It calls into question the sovereignty of the Republic of Macedonia and the freedoms of certain parts of its citizenry and violates its authority as an independent state possessing the same rights and entitlements as other states. Good neighbourliness can only be constructed on the basis of equality and good will and not by means of blackmail, humiliation and abuse of one’s position of power.

By means of this agreement Macedonia has taken a further step towards its abandonment of the Macedonian minority in Bulgaria. The earlier declarative abandonment has now become part of the Agreement on “Good Neighbourliness”. That is a logical and shameful next step which comes after 25 years of violation of the Constitution by the governments of the Republic of Macedonia which have completely and consistently ignored their constitutional obligation to care for and protect the rights of the Macedonian minorities in the neighbouring countries and especially in Bulgaria and Greece. The agreement is anti-constitutional precisely for this reason!

Macedonia, via this agreement, in accordance with the views of Bulgaria, undertakes that not only will it not make representations on behalf of the Macedonian minority and support its organisations in Bulgaria (Article 11.5), something which it has not done up until now anyway, but also will not allow any activities by such organisations to occur on its territory or allow activities by its own citizens on Macedonian territory which support such organisations (Article 11.2). Nor will it allow media coverage of the activities and problems experienced by Macedonian organisations and the Macedonian minority in Bulgaria (Article 11.6)

In addition, it creates a mechanism thorough which Bulgaria can place certain conditions on and blackmail Macedonia during the process relating to its integration into European and Atlantic structures. (Articles 8 and 12). It creates the possibility for Bulgaria to intervene in independent academic research and media freedoms and imposes a redefinition of concepts such as hate speech in relation to each and every opinion which supports the notion that Macedonians are a separate and distinct national and ethnic group. The statements of certain officials in Bulgaria bear witness to the fact that this is indeed Bulgaria’s intention and that the agreement is but a first step and not a final solution, despite attempts by certain naive politicians in Skopje to portray it as such.

The terminology used: “two states and their peoples”, “the Macedonian language, according to the Constitution of the Republic of Macedonia”, “joint history” relativises the Macedonian nation. Joint celebrations of whatever type in a situation where the Macedonian nation and identity are openly denied by Bulgaria will only serve to satisfy such negation and will not contribute to overcoming any misunderstandings which may exist.

This agreement represents an unprecedented interference of politics in the study of history-it prescribes the formation of political bodies which will interpret history and report back to their respective governments. We wish to remind that history is a science and any kind of interference by politicians in its study is inadmissible. This represents but another tool for blackmail through which Bulgaria will insist on the acceptance of the Bulgarian view of the history of Macedonia becoming a condition for the gaining of membership of European institutions under the guise of “good neighbourliness”.

We therefore consider the Agreement unacceptable, insulting to Macedonia and the Macedonian people, unprincipled and shameful for both signatory countries. In addition, contrary to the expectations of the signatories, it will not contribute to good neighbourliness, but will only increase mistrust and create genuine hate of Bulgaria, instead of the imaginary hate that Sofia now complains of.

Neither the Macedonian minority in Bulgaria, the Macedonian Diaspora, and we are convinced, the Macedonian nation in general feel bound in any way by the unequal clauses of this agreement. They will oppose every attempt to limit their human freedoms, will continue their struggle for dignity, rights and justice and oppose every attempt to prevent that struggle from continuing, irrespective of whether it emanates from Sofia or Skopje.

OMO “Ilinden” – PIRIN
Macedonian Human Rights Movement International
Australian-Macedonian Human Rights Committee
Macedonian Alliance for European Integration – Albania

— Macedonian Human Rights Movement International (MHRMI) has been active on human and national rights issues for Macedonians and other oppressed peoples since 1986. For more information: 1-416-850-7125,,,,,

Bill Nicholov, President
Macedonian Human Rights Movement International
email us here

Source: EIN Presswire